View Alert
Originator: DHSC Supply Disruption Alert

Issue date: 01-Aug-2019 10:29:18

Action by recipients:
  • Care Trusts
  • Mental Health Trusts
  • Specialists Trusts
  • NHS Regional Offices
  • Learning Disabilities Trusts
  • Mental Health & Social Care Trusts
  • Ambulance Trusts
  • Mental Health & Learning Disabilities
  • Acute Trusts
  • Community Trusts

Information to recipients:
  • MHRA (Medicines) Drug Alerts (Various Recipients)
  • Other contacts
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups
  • Ofsted recipients
  • Social Care Providers (registered with CAS)
  • Special Health Authorities
  • MHRA (Medicines) Drug Alerts - Non-NHS Recipients
  • Director of Public Health

Action category: Action

Title: Emerade 500 microgram and 300 microgram adrenaline auto-injector devices

Broadcast content:
Emerade 500 microgram and 300 microgram devices manufactured by Bausch & Lomb UK will be experiencing a short-term disruption in supply.

Emerade 500 microgram is out of stock until the 28 August 2019.

Emerade 300 microgram has limited supplies remaining but will be out of stock from early-mid August with further supplies expected by 30 September 2019.

This alert sets out a management plan for organisations to follow in managing stock.


Additional information: NHS England Regional Offices - please cascade to primary care.

Alert reference: SDA/2019/004

Action underway deadline: 05-Aug-2019

Action complete deadline: 30-Sep-2019

Attachments:

Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency